Global Intraocular Lens Market By Type (Non-Foldable Lenses, and Foldable Intraocular Lens), By Application (Treat Cataracts), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Intraocular Lens Market By Type (Non-Foldable Lenses, and Foldable Intraocular Lens), By Application (Treat Cataracts), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Intraocular Lens by Product Type(Monofocal IOL, Multifocal IOL, Toric IOL, Accommodative IOL, Others), by End User (Hospitals, ASCs, Eye Clinics, Others), by Flexibility Type (Non-Foldable Lenses, Foldable Lenses) and by Region -Global Forecast to 2030, which offers a holistic view of the global intraocular lens market through systematic segmentation that covers every aspect of the target market.

The global intraocular lens market is projected to be US$ 3,136.6 Mn in 2020 to reach US$ 5,432.4 Mn by 2030 at a CAGR of 5.6%.

An intraocular lens is an artificial lens made up of synthetic materials like silicone, hydrophilic or hydrophobic acrylate, PMMA or any other material, and is implanted into the eyes during cataract surgery to help the patient regain the normal vision. Historically, the first intraocular lenses to be discovered were rigid lenses made up of Poly methyl methacrylate (PMMA). These lenses are non-foldable and require a comparatively larger incision to be implanted into a patients eye. But, with the advent of new technology intraocular lenses made up of flexible materials like silicone or acrylate are now available which have several advantages over the conventional PMMA intraocular lenses. The global market for intraocular lenses is expected to grow with a steady pace in the forecast period owing to the increasing prevalence of cataract and betterment of healthcare infrastructure.

Dramatically rising geriatric population globally is expected to be the primary factor driving the growth of the global intraocular lens market. In addition to this, increasing healthcare expenditure in emerging nations is expected to aid market growth for intraocular lens.

Furthermore, factor such as technological advancements of intraocular lenses, which helps in cataract surgery with a tiny incision is other factors expected to fuel the growth of the target market.


Global Intraocular Lens Market Revenue (US$ Mn), 2021 to 2030


However, the high cost of the foldable intraocular lens is expected to challenge the growth of intraocular lens market. Also, the lack of awareness about minimally invasive surgery of cataract in some emerging nations is also expected to hinder the market growth. Nonetheless, favourable market conditions for minimally invasive surgeries provide lucrative opportunities for global intraocular lens market to grow.

Global intraocular lens market is segmented on the basis of product type, end-user, flexibility type and region. On the basis of product type, the market is segmented into monofocal IOL, multifocal IOL, toric IOL, accommodative IOL and others. Monofocal IOL segment accounts for the majority share in the global intraocular lens market, while the Toric IOL is expected to register the highest growth rate over the forecast period. On the basis of end user, the market is segmented into hospitals, ASCs, eye clinics and others. Hospitals account for a majority share in the global intraocular lens market. On the basis of flexibility type market is segmented into non-foldable lenses and foldable lenses, in which foldable lenses account for majority market share.


Global Intraocular Lens Market by Product Type, 2018


On the basis of region, the market is segmented into USA, Europe, China, India, Japan and Southeast Asia. The USA accounts for the majority share in the global intraocular lens market, followed by Europe, owing to the increasing prevalence of cataract and betterment of healthcare infrastructure in the region. Economies such as India are expected to register the highest growth rate over the forecast period. Countries and regions such as Japan, Southeast Asia and Europe are expected to register stable growth over the forecast period.

The research report on the global intraocular lens market includes profiles of some of major companies such as Novartis AG, HOYA CORPORATION, Bausch & Lomb Incorporated, Carl Zeiss AG, Ophtec BV., Rayner Surgical Group Limited, STAAR Surgical Company, Lenstec, Inc., HumanOptics AG, Bio-Tech Vision Care, Omni Lens Pvt Ltd, SAV-IOL SA, PhysIOL s.a, Aurolab, Eagle Optics and SIFI S.p.A.


Below are the active patents related to Intraocular Lens Market.


Patent Number: US9737396B2

Foldable intraocular lens and method of making

Abstract

A foldable intraocular lens for providing vision contains an optic body that includes an optical zone and a peripheral zone entirely surrounding the optical zone. The optic body has an anterior face, a substantially opposing posterior face, an optic edge, and an optical axis. The anterior face comprises a central face, a peripheral face, and a recessed annular face therebetween that is disposed posterior to the peripheral face. The intraocular lens further comprises at least one haptic that is integrally formed with the peripheral zone. The haptic comprises a distal posterior face, a proximal posterior face, and a step edge disposed at a boundary therebetween. The haptic further comprises a side edge disposed between the optic edge and the step edge. The proximal posterior face and the posterior face of the optic body form a continuous surface. An edge corner is formed by the intersection of the continuous surface with the optic edge, the side edge, and the step edge.

Application File Date: 2016-02-12

Application Granted Date: 2017-08-22

Current Assignee: Johnson and Johnson Surgical Vision Inc

Patent Number: US20080086146A1

Intraocular Lens Implanting Device

Abstract

An intraocular lens implanting device capable of inserting an intraocular lens surely in safety into an eyeball and having an ophthalmic hooking function capable of adjusting the position of the intraocular lens. The intraocular lens implanting device for inserting an intraocular lens into an eyeball through an incision in the eyeball tissue comprises a tubular main body, a storage part for the intraocular lens integrated with the main body or separated therefrom, and a plunger for pressing the intraocular lens placed in the containing section and discharging it into the eyeball, wherein the distal end of the plunger has a base part and a protuberance.

Application File Date: 2005-12-19

Application Granted Date: 2013-06-11

Current Assignee: Hoya Corp

Patent Number: US20040106992A1

Multi-zonal monofocal intraocular lens for correcting optical aberrations

Abstract

A multi-zonal monofocal opthalmic lens comprises an inner zone, an intermediate zone, and an outer zone. The inner zone has a first optical power. The intermediate zone surrounds the inner zone and has a second optical power that is different from the first power by a magnitude that is less than at least about 0.75 Diopter. The outer zone surrounds the intermediate zone and has a third optical power different from the second optical power. In certain embodiments, the third optical power is equal to the first optical power.

Application File Date: 2003-11-10

Application Granted Date: 2008-06-03

Current Assignee: Johnson and Johnson Surgical Vision Inc

Key Market Segments:

By Product

  
Monofocal IOL
  
Multifocal IOL
  
Toric IOL
  
Accommodative IOL

By End-use

  
Hospitals
  
Ophthalmic Clinics
  
Ambulatory Care Centers
  
Eye Research Institutes


Key Market Players included in the report:


  
Alcon Inc. (US)
  
Aurolab (India)
  
Bausch Health Companies Inc.
  
Bio-Tech Vision Care
  
Care Group (India)
  
Carl Zeiss Meditec (Germany)
  
Eagle Optics and SIFI S.p.A
  
EyeKon Medical Inc.
  
Hanita Lenses R.C.A Ltd. (Israel)
  
HOYA Corporation (Japan)
  
HumanOptics AG
  
Johnson & Johnson Vision Care Inc. (US)
  
Lenstec Inc.
  
NIDEK CO.LTD. (Japan)
  
Novartis AG
  
Oculentis GmbH (Germany)
  
Omni Lens Pvt. Ltd. (India)
  
Ophtec BV (Netherlands)
  
PhysIOL (Belgium)
  
Rayner Intraocular Lenses Limited (UK)
  
Rayner Surgical Group Limited
  
SAV-IOL SA
  
STAAR Surgical Company (US)
  
Swiss Advanced Vision (SAV IOL) (Switzerland)
  
Valeant


Below are the key development related to Intraocular Lens Market in 2020 and 2021.


January 2021: Alcon launches extended depth of focus intraocular lens. Alcon (NYSE:ALC) announced that it launched the first and only non-diffractive extended depth of focus intraocular lens in the U.S. Geneva, Switzerland-based Alcon’s AcrySof IQ Vivity IOL, a presbyopia-mitigating lens, is now available to all U.S. ophthalmologists for use with patients who are undergoing cataract surgery. AcrySof IQ Vivity uses Alcon’s proprietary non-diffractive X-Wave technology, which stretches and shifts light without splitting it to deliver monofocal-quality distance vision, strong intermediate vision and functional near vision. The IOL received FDA approval in February 2020 and was made available to select U.S. ophthalmologists during a September 2020 pilot phase. The lens is already available in some European markets, along with Australia, New Zealand and Canada, with the company touting more than 125 million implants of the AcrySof IQ platform around the world so far.Source

December 2020: RxSight secures $60M credit facility. RxSightOxford Finance announced that it closed a $60 million senior secured term loan with intraocular lens maker RxSight. Aliso Viejo, Calif.-based RxSight develops what it touts as the world’s first and only FDA-approved adjustable intraocular lens that is customized after cataract surgery. RxSight’s lens is designed to deliver superior visual outcomes with its post-cataract surgery customization capabilities offering the ability to meet the patient’s personal desires and lifestyle requirements. Approximately 100 U.S. surgeons are using RxSight’s lens in their cataract patients.RxSight plans to use the funds generated from the $60 million term loan for general working capital, including sales and marketing along with research and development. Source

October 2020: BVI® acquires Benz Research & Development, strengthening end to end IOL design, production and sales capabilities. Benz R&D is the leading technologically advanced independent supplier of performance materials and manufacturing technology to the IOL industry. BVIs vertical integration will accelerate manufacturing capacity and geographic sales expansion, and the IOL material capabilities of BVIs world leading PhysIOL® lens platform. BVI, the fastest-growing diversified company in ophthalmology, announced its recent completion of the acquisition of Benz Research & Development (Benz) and its customized contact lens subsidiary, SpecialEyes, both based in Sarasota, Florida. Source